Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;70(11):3210-3220.
doi: 10.1111/jgs.17975. Epub 2022 Jul 30.

Institutional, therapeutic, and individual factors associated with 30-day mortality after COVID-19 diagnosis in Canadian long-term care facilities

Affiliations

Institutional, therapeutic, and individual factors associated with 30-day mortality after COVID-19 diagnosis in Canadian long-term care facilities

Xi Sophie Zhang et al. J Am Geriatr Soc. 2022 Nov.

Abstract

Background: Canadian long-term care facility (LTCF) residents experienced higher death rates compared to other countries during the first wave of the COVID-19 pandemic. This cohort study analyzes the individual, therapeutic, and institutional factors associated with death in LTCFs.

Methods: Institutional data for 17 LTCFs in Montreal, Canada were obtained from local administrative registries. Individual data for 1197 residents infected by SARS-CoV-2 between February 23 and July 11, 2020 were obtained through chart reviews. A multivariable modified Poisson regression model, which accounted for LTCF clustering, was used to identify resident and facility covariates associated with 30-day mortality after COVID-19 diagnosis.

Results: Severe shortage of licensed practical nurses (RR 2.60 95% CI 1.20-5.61) and medium-sized facilities compared to smaller-sized facilities (RR 2.73 95% CI 1.23-6.07) were associated with 30-day mortality. Later COVID-19 diagnosis (RR 0.98 95% CI 0.97-0.99 per additional day) was associated with survival. Individual risk factors for death included age (RR 1.33 95% CI 1.23-1.45 per additional 10 years), male sex (RR 1.46 95% CI 1.24-1.71), functional impairment (RR 1.08 95% CI 1.04-1.12 per unit increase of SMAF), as well as a diagnosis of congestive heart failure (RR 1.31 95% CI 1.04-1.66) and neurocognitive disorder (RR 1.31 95% CI 1.01-1.70). Among severe cases, anticoagulation was associated with survival (RR 0.70 95% CI 0.51-0.96).

Conclusions: This study identified practical nurse shortages and facility size as institutional risk factors for COVID-19 death. Anticoagulation was associated with survival among severe cases.

Keywords: COVID-19; death; long-term care.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts and have completed the ICMJE uniform disclosure form at http://www.icmje.org/disclosure-of-interest/.

Figures

FIGURE 1
FIGURE 1
Factors associated with 30‐day mortality after COVID‐19 diagnosis

References

    1. Sepulveda ER, Stall NM, Sinha SK. A comparison of COVID‐19 mortality rates among long‐term care residents in 12 OECD countries. J Am Med Dir Assoc. 2020;21(11):1572‐1574. doi: 10.1016/j.jamda.2020.08.039 - DOI - PMC - PubMed
    1. Stratil JM, Biallas RL, Burns J, et al. Non‐pharmacological measures implemented in the setting of long‐term care facilities to prevent SARS‐CoV‐2 infections and their consequences: a rapid review. Cochrane Database Syst Rev. 2021;9(9):CD015085. doi: 10.1002/14651858.CD015085.pub2 - DOI - PMC - PubMed
    1. Dykgraaf SH, Matenge S, Desborough J, et al. Protecting nursing homes and long‐term care facilities from COVID‐19: a rapid review of international evidence. J Am Med Dir Assoc. 2021;22(10):1969‐1988. doi: 10.1016/j.jamda.2021.07.027 - DOI - PMC - PubMed
    1. Prendki V, Tau N, Avni T, et al. A systematic review assessing the under‐representation of elderly adults in COVID‐19 trials. BMC Geriatr. 2020;20(1):538. doi: 10.1186/s12877-020-01954-5 - DOI - PMC - PubMed
    1. Su Z, McDonnell D, Li Y. Why is COVID‐19 more deadly to nursing home residents? QJM. 2021;114:543‐547. doi: 10.1093/qjmed/hcaa343 - DOI - PMC - PubMed